Daewoong Pharmaceutical Co., Ltd
Research Daewoong Pharmaceutical Co., Ltd (069620.KS) on Bullrun: market cap KRW 1.21T, dividend yield 0.6%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker069620.KS
- ExchangeKS
- CountrySouth Korea
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyKRW
- Market capKRW 1.21T
- Dividend yield0.6%
- Financial periodQ2 2026
- RevenueKRW 448.46B
- Net incomeKRW 33.37B
- Free cash flow-KRW 20.14B
- Gross margin55.5%
Valuation Snapshot
latest market cap is KRW 1.21T; dividend yield is 0.6%.
Peer valuation comparison
Latest dividend yield is 0.59% versus a Healthcare sector median of 2.4% (75.4% below).
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | KRW 1.21T | n/a | 0.6% | 600 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 600 KRW, yield 0.6%.
About Daewoong Pharmaceutical Co., Ltd
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins.
ETFs that hold Daewoong Pharmaceutical Co., Ltd
US-listed ETFs
Daewoong Pharmaceutical Co., Ltd is held by 22 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard FTSE Developed Markets Index Fund ETF Shares (VEA) | <0.01% | 0.03% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| iShares Core MSCI Total International Stock ETF (IXUS) | <0.01% | 0.07% |
| Avantis Emerging Markets Equity ETF (AVEM) | <0.01% | 0.33% |
| Vanguard FTSE Pacific Index Fund ETF Shares (VPL) | <0.01% | 0.07% |
| Vanguard FTSE All-World ex-US Small-Cap Index Fund ETF Shares (VSS) | 0.01% | 0.06% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Daewoong Pharmaceutical Co., Ltd's market cap?
Daewoong Pharmaceutical Co., Ltd's market capitalization is KRW 1.21T.
Does Daewoong Pharmaceutical Co., Ltd pay a dividend?
Daewoong Pharmaceutical Co., Ltd has a dividend yield of 0.6%.
What does Daewoong Pharmaceutical Co., Ltd do?
Daewoong Pharmaceutical Co., Ltd. develops, manufactures and commercializes pharmaceutical products in South Korea and internationally. It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins. The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices.